Celularity is a biotechnology company productizing allogeneic cells and tissues derived from the postpartum placenta. These materials have the ability to augment our immunity and longevity by amplifying the body’s ability to fight disease, heal, and regenerate itself. Celularity is using stem cells derived from the placenta to create transformative therapeutic options for complex medical conditions from cancer to Crohn’s disease. Celularity has over a dozen pre-clinical trials and Investigational New Drug applications (IND) in progress.
Some data provided by Crunchbase
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Celularity or any companies featured above.
This profile is based on publicly available information and is intended to be informative in nature.
To learn more about whether you're eligible, typical investment size, company valuation, and share price, request access here.